Global Dercum’s Disease Treatment Market, By Symptoms (Weight Gain, Swelling, Fatigue, Weakness, Depression, Headaches, Irritability, Difficulty Sleeping, Rapid Heart Rate, Shortness Of Breath, Easy Bruising, Stiffness, Constipation, Problems With Thinking, Concentration, and Or Memory), Treatment (Acupuncture, Surgery, Electrotherapy, Medication, Liposuction, and Others) Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), End User (Ambulatory Surgical Centers, Hospitals, Clinics, and Others) - Industry Trends and Forecast to 2030.
Dercum’s Disease Treatment Market Analysis and Size
Dercum’s disease, also termed adipose Dolorosa, is a rare condition characterized by multiple painful growths of fatty tissue called lipomas. The disease mostly affects the torso, the upper arms, and legs. The increase in healthcare expenditures in developed and developing economies is expected to accelerate the market growth in the forecast period of 2023 to 2030. Likewise, the rapid rise in the prevalence of rare diseases and the prevalence of patients are also predictable to enhance the global dercum’s disease treatment market growth. Furthermore, the favorable reimbursement scenario and comparatively large number of research and development (R&D) activities are also projected to drive the market growth rate. Also, the increase in disposable income and government funding for the healthcare sector is expected to influence the global dercum’s disease treatment market growth.
Data Bridge Market Research analyses that the global dercum’s disease treatment market is expected to undergo a CAGR of 7.10% during the forecast period. “Acupuncture” dominates the treatment segment of the global dercum’s disease treatment market owing to the rapid rise in the prevalence of rare diseases and rise in the prevalence of patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Dercum’s Disease Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Symptoms (Weight Gain, Swelling, Fatigue, Weakness, Depression, Headaches, Irritability, Difficulty Sleeping, Rapid Heart Rate, Shortness of Breath, Easy Bruising, Stiffness, Constipation, Problems with Thinking, Concentration, Or Memory), Treatment (Acupuncture, Surgery, Electrotherapy, Medication, Liposuction, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), End User (Ambulatory Surgical Centers, Hospitals, Clinics, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA)
|
|
Market Players Covered
|
|
|
Market Opportunities
|
|
Market Definition
Adiposis dolorosa, another name for dercum's disease, is an uncommon disorder marked by the emergence of numerous painful lipomas or growths of fatty tissue. Although these lipomas can develop anywhere on the body, the trunk, upper arms, and upper legs are where they most frequently appear. Dercum's disease, which primarily affects females, still has no identified cause. Dercum's disease is primarily managed by pain management and symptom management. No particular treatment is available for it because it is a rare disorder with an unclear underlying cause. For those with dercum's disease, numerous therapy approaches can be employed to reduce symptoms and enhance the quality of life.
Global Dercum’s Disease Treatment Market Dynamics
Drivers
- Increasing research and development activities
Innovation in the medical industry may be sparked by ongoing research and development initiatives aiming to comprehend the fundamental mechanics of dercum's illness and locate possible therapeutic targets. New medications, treatments, and techniques for dercum's disease may be developed due to treatment advances in scientific understanding, which is expected to drive market growth.
- Improved diagnostic tools for treatment
Early detection and prompt treatment of dercum's illness can benefit from developing more precise and effective diagnostic technologies. To help diagnose and track disease development, this can entail improvements in imaging techniques, genetic testing, or the identification of biomarkers, which is expected to drive the market growth.
- Increasing awareness regarding the disease and its diagnosis
There is a rising need for efficient treatment alternatives as medical experts and the general public's awareness of dercum's disease increases. By raising awareness, pharmaceutical companies may be persuaded to spend more on research and development and developing novel medicines, which is expected to drive the market growth.
Opportunities
- Rising focus on personalized medicine
Dercum's illness is a complicated ailment that manifests differently in each person. There is a chance to create personalized medicine strategies that consider every patient’s special quality and requirement and customize treatment regimens for specific individuals, one may utilise precision medicine approaches like genomic profiling and biomarker identification, which creates an opportunity for the market growth.
- Rising therapeutic innovations
There is potential for therapeutic advancements and the creation of cutting-edge therapy modalities that are especially geared toward controlling dercum's disease symptoms. Treat the underlying processes of the illness also includes researching novel pharmacological therapies, focused biologics, or gene therapies.
- Increasing collaborations and partnerships among key players
Collaboration between pharmaceutical firms, academic institutions, and advocacy organizations can make sharing information, resources, and skills easier. Such partnerships can hasten the development of therapy options and increase patients' access to them.
Restraint
- High treatment costs
The expenses related to consultations, diagnostic tests, pain management, and supportive care can add significantly to the cost of managing dercum's disease. Individuals may struggle with the financial load, especially when insurance coverage is insufficient or non-existent, which is expected to restrain the market growth.
- Adverse effects after the treatment
For severe cases of dercum's disease, surgical removal of lipomas is a therapy option, although it includes risks and may not always provide long-term relief. After surgery, lipomas might return, resulting in lingering discomfort and the need for additional treatments.
Challenges
- Limited awareness about the disease
Due to the rarity of dercum's disease, many medical experts might not be familiar with it. The condition may not be properly treated or managed due to underdiagnoses, incorrect diagnosis, or delayed diagnosis.
- Lack of reimbursement and coverage policies
Finding compensation and insurance coverage may be difficult due to the high expenses of specialized care and supporting care for uncommon diseases. This may make it more difficult for patients to fund necessary therapies.
This dercum’s disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dercum’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Dercum’s Disease Treatment Market Scope
The global dercum’s disease treatment market is segmented on the basis of symptoms, treatment, distribution channel, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Symptoms
- Weight gain
- Swelling
- Fatigue
- Weakness
- Depression
- Headaches
- Irritability
- Difficulty sleeping
- Rapid heart rate
- Shortness of breath
- Easy bruising
- Stiffness
- Constipation and problems with thinking
- Concentration or memory
Treatment
- Acupuncture
- Surgery
- Electrotherapy
- Medication
- Liposuction
- Others
End User
- Ambulatory Surgical Centers
- Hospitals
- Clinics
- Others
Distribution channel
- Hospital pharmacies
- Retail pharmacies
- Others
Global Dercum’s Disease Treatment Market Regional Analysis/Insights
The global dercum’s disease treatment market is analyzed, and market size information is provided by country by symptoms, treatment, distribution channel, and end user as referenced above.
The countries covered in the global dercum’s disease treatment market report are the U.S., Canada and Mexico in North America, Peru, Brazil, Argentina, and the Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America, dominates the global dercum’s disease treatment market due to the well-established healthcare sector, rise in the prevalence of rare diseases and rise in healthcare expenditure.
Asia-Pacific region is expected to grow significantly in the forecast period of 2023 to 2030 because of the rise in disposable income, constantly developing economies, and government funding for the healthcare sector.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global dercum’s disease treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, and adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period. The data is available for historic period 2015 to 2021.
Competitive Landscape and Celiac Disease Treatment Market Share Analysis
The global dercum’s disease treatment market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus on the global dercum’s disease treatment market.
Some of the major players operating in the global dercum’s disease treatment market are:
- AbbVie Inc. (U.S.)
- Merck & Co., Inc. (U.S.)
- Novartis AG (Switzerland)
- F. Hoffman La –Roche (Switzerland)
- GlaxoSmithKline plc (U.K.)
- Bausch Health Companies Inc. (Canada)
- AstraZeneca (U.K.)
- Sanofi (France)
- Amgen Inc. (U.S.)
- Lilly (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Syneron Medical (U.S.)
- Alimed Inc. (U.S.)
- Pfizer Inc. (U.S.)
SKU-